This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: University of Central Florida Research Foundation Inc., University of Colorado. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Innovations in Wound Healing by Robert Gorman
Introduction
Robert Gorman is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of wound treatment and tissue regeneration. His innovative approach utilizes microRNA-146A and nanoceria conjugates to enhance healing processes.
Latest Patents
Gorman holds a patent for the "Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration." This patent focuses on advanced methods for treating wounds and promoting tissue regeneration after injuries. It specifically addresses the use of microRNA-146a and nanoceria conjugates to improve wound healing and prevent adverse ventricular remodeling following myocardial infarction. He has 1 patent to his name.
Career Highlights
Throughout his career, Gorman has worked with prestigious institutions, including the University of Colorado and the University of Central Florida Research Foundation Inc. His work has been pivotal in advancing medical treatments related to wound healing.
Collaborations
Gorman has collaborated with notable professionals in his field, including Sudipta Seal and Kenneth Liechty. Their combined expertise has contributed to the development of innovative solutions in wound treatment.
Conclusion
Robert Gorman's work in the field of wound healing exemplifies the impact of innovative research on medical treatments. His contributions continue to influence advancements in tissue regeneration and healing therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile